190 related articles for article (PubMed ID: 30998419)
1. Jet milling industrialization of sticky active pharmaceutical ingredient using quality-by-design approach.
Nakach M; Authelin JR; Corsini C; Gianola G
Pharm Dev Technol; 2019 Sep; 24(7):849-863. PubMed ID: 30998419
[TBL] [Abstract][Full Text] [Related]
2. New Approach and Practical Modelling of Bead Milling Process for the Manufacturing of Nanocrystalline Suspensions.
Nakach M; Authelin JR; Agut C
J Pharm Sci; 2017 Jul; 106(7):1889-1904. PubMed ID: 28302540
[TBL] [Abstract][Full Text] [Related]
3. Towards integrated drug substance and drug product design for an active pharmaceutical ingredient using particle engineering.
Kougoulos E; Smales I; Verrier HM
AAPS PharmSciTech; 2011 Mar; 12(1):287-94. PubMed ID: 21246419
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
[TBL] [Abstract][Full Text] [Related]
5. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
7. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
8. Nano-sized crystalline drug production by milling technology.
Moribe K; Ueda K; Limwikrant W; Higashi K; Yamamoto K
Curr Pharm Des; 2013; 19(35):6246-58. PubMed ID: 23470002
[TBL] [Abstract][Full Text] [Related]
9. Effect of powder processing on performance of fenofibrate formulations.
Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
[TBL] [Abstract][Full Text] [Related]
10. Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.
Siewert C; Moog R; Alex R; Kretzer P; Rothenhäusler B
Eur J Pharm Sci; 2018 Mar; 115():126-131. PubMed ID: 29278757
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
[TBL] [Abstract][Full Text] [Related]
12. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
13. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
Casas M; Aguilar-de-Leyva Á; Caraballo I
Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
[TBL] [Abstract][Full Text] [Related]
14. Process optimization and particle engineering of micronized drug powders via milling.
Brunaugh A; Smyth HDC
Drug Deliv Transl Res; 2018 Dec; 8(6):1740-1750. PubMed ID: 29134556
[TBL] [Abstract][Full Text] [Related]
15. Monitoring process induced attrition of drug substance particles within formulated blends.
Gamble JF; Hoffmann M; Hughes H; Hutchins P; Tobyn M
Int J Pharm; 2014 Aug; 470(1-2):77-87. PubMed ID: 24793838
[TBL] [Abstract][Full Text] [Related]
16. Salt-kneading: alternative sizing of active pharmaceutical ingredients?
Šimek M; Vyňuchal J; Tomášová L
Pharm Dev Technol; 2016 Dec; 21(8):972-979. PubMed ID: 26365246
[TBL] [Abstract][Full Text] [Related]
17. Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients.
Hussain A; Smith G; Khan KA; Bukhari NI; Pedge NI; Ermolina I
Eur J Pharm Sci; 2018 Oct; 123():395-403. PubMed ID: 30076953
[TBL] [Abstract][Full Text] [Related]
18. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
[TBL] [Abstract][Full Text] [Related]
19. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
[TBL] [Abstract][Full Text] [Related]
20. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
Wenzel T; Stillhart C; Kleinebudde P; Szepes A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
